Skip to content

Clinical trials

Phase 1 Carcinoma, Bronchogenic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Bronchogenic Phase: Phase 1 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20111
20122
20131
20181
20212
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated4
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation3
Revolution Medicines, Inc.2
H. Lee Moffitt Cancer Center and Research Institute1
National Institutes of Health Clinical Center (CC)1
Pharmacyclics LLC.1
Shanghai Yunying Medical Technology1
Syndax Pharmaceuticals1
VA Office of Research and Development1
Valerio Therapeutics1
Wuxi No. 4 People's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Bronchogenic13
Carcinoma, Non-Small-Cell Lung11
Lung Neoplasms11
Neoplasms10
Lung Diseases8
Neoplasms by Site8
Thoracic Neoplasms8
Respiratory Tract Diseases7
Respiratory Tract Neoplasms7
Bronchial Neoplasms6

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.